Anne Klibanski
#107,777
Most Influential Person Now
Researcher
Anne Klibanski's AcademicInfluence.com Rankings
Anne Klibanskichemistry Degrees
Chemistry
#2011
World Rank
#2851
Historical Rank
Organic Chemistry
#279
World Rank
#342
Historical Rank
Anne Klibanskibiology Degrees
Biology
#5773
World Rank
#8334
Historical Rank
Molecular Biology
#552
World Rank
#565
Historical Rank
Neuroscience
#669
World Rank
#699
Historical Rank
Download Badge
Chemistry Biology
Anne Klibanski's Degrees
- Bachelors Chemistry Stanford University
Why Is Anne Klibanski Influential?
(Suggest an Edit or Addition)Anne Klibanski's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Osteoporosis prevention, diagnosis, and therapy. (2001) (3506)
- Osteoporosis prevention, diagnosis, and therapy. (2000) (1251)
- Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. (1996) (780)
- A consensus on criteria for cure of acromegaly. (2010) (712)
- Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. (1998) (652)
- MEG3 noncoding RNA: a tumor suppressor. (2012) (642)
- Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. (2008) (618)
- Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist (2001) (591)
- Activation of p53 by MEG3 Non-coding RNA* (2007) (568)
- Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. (2000) (499)
- The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. (1995) (455)
- Serum leptin levels in women with anorexia nervosa. (1996) (439)
- Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume. (2003) (428)
- Osteopenia in men with a history of delayed puberty. (1992) (422)
- A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. (2003) (401)
- Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. (1989) (397)
- Bone marrow adipose tissue is an endocrine organ that contributes to increased circulating adiponectin during caloric restriction. (2014) (392)
- Prevalence and Predictive Factors for Regional Osteopenia in Women with Anorexia Nervosa (2000) (387)
- Expert consensus document: A consensus on the medical treatment of acromegaly (2014) (372)
- Reduction of plasma immunoreactive somatomedin C during fasting in humans. (1981) (368)
- Clinically nonfunctioning pituitary tumors are monoclonal in origin. (1990) (360)
- Current concepts: Eating disorders. (1999) (359)
- The effects of anorexia nervosa on bone metabolism in female adolescents. (1999) (352)
- Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. (1988) (350)
- Increased bone marrow fat in anorexia nervosa. (2009) (343)
- Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanoma. (2014) (342)
- A Consensus Statement on acromegaly therapeutic outcomes (2018) (325)
- Abnormal bone mineral accrual in adolescent girls with anorexia nervosa. (2002) (320)
- Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. (2002) (318)
- Effects of Anorexia Nervosa on Clinical, Hematologic, Biochemical, and Bone Density Parameters in Community-Dwelling Adolescent Girls (2004) (317)
- Marrow fat and bone--new perspectives. (2013) (314)
- Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. (2010) (308)
- Medical findings in outpatients with anorexia nervosa. (2005) (297)
- Region-specific variation in the properties of skeletal adipocytes reveals regulated and constitutive marrow adipose tissues (2015) (297)
- Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. (2004) (291)
- Osteoporosis in Men with Idiopathic Hypogonadotropic Hypogonadism (1987) (291)
- A consensus on the diagnosis and treatment of acromegaly complications (2012) (289)
- Alterations in cortisol secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. (2003) (288)
- Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions. (2010) (285)
- Effects of Physiologic Growth Hormone Therapy on Bone Density and Body Composition in Patients with Adult-Onset Growth Hormone Deficiency (1996) (284)
- Estradiol Modulates Medial Prefrontal Cortex and Amygdala Activity During Fear Extinction in Women and Female Rats (2011) (281)
- Vertebral Bone Marrow Fat Is Positively Associated With Visceral Fat and Inversely Associated With IGF‐1 in Obese Women (2011) (274)
- Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa (2011) (274)
- The influence of gonadal hormones on conditioned fear extinction in healthy humans (2010) (273)
- Octreotide treatment of acromegaly. A randomized, multicenter study. (1992) (270)
- Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center study. (1995) (258)
- Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. (1996) (255)
- Octreotide as primary therapy for acromegaly. (1998) (253)
- Osteoporosis in men with hyperprolactinemic hypogonadism. (1986) (250)
- Current treatment guidelines for acromegaly. (1998) (237)
- Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting. (1996) (234)
- Ras mutations in human pituitary tumors. (1992) (232)
- Elevated peptide YY levels in adolescent girls with anorexia nervosa. (2006) (230)
- Effects of Androgen Administration in Men with the AIDS Wasting Syndrome (1998) (225)
- Visceral fat is a negative predictor of bone density measures in obese adolescent girls. (2010) (222)
- Decreased bone density in hyperprolactinemic women. (1980) (222)
- Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting. (1997) (218)
- Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea. (1999) (218)
- Somatostatin receptor subtype gene expression in pituitary adenomas. (1995) (216)
- Determinants of skeletal loss and recovery in anorexia nervosa. (2006) (214)
- A critical analysis of pituitary tumor shrinkage during primary medical therapy in acromegaly. (2005) (212)
- Endocrine consequences of anorexia nervosa. (2014) (206)
- Bone, fat, and body composition: evolving concepts in the pathogenesis of osteoporosis. (2009) (206)
- Treatment of prolactin-secreting macroadenomas with the once-weekly dopamine agonist cabergoline. (1996) (202)
- Clinical review 75: Recent advances in pathogenesis, diagnosis, and management of acromegaly. (1995) (201)
- Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors. (2005) (200)
- Increase in bone mass after treatment of hyperprolactinemic amenorrhea. (1986) (196)
- Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. (1994) (196)
- Secretory dynamics of leptin in adolescent girls with anorexia nervosa and healthy adolescents. (2005) (194)
- Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study. (2006) (193)
- Fear conditioning and extinction: influence of sex and menstrual cycle in healthy humans. (2006) (192)
- A longitudinal evaluation of bone mineral density in adult men with histories of delayed puberty. (1996) (190)
- The effects of SOM230 on cell proliferation and adrenocorticotropin secretion in human corticotroph pituitary adenomas. (2006) (186)
- Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism. (1989) (184)
- Assessment of macronutrient and micronutrient intake in women with anorexia nervosa. (2000) (182)
- Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency. (1998) (182)
- Clinical practice. Prolactinomas. (2010) (180)
- Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement (2017) (179)
- Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement (2017) (179)
- Abnormal cortisol secretion and responses to corticotropin-releasing hormone in women with hypothalamic amenorrhea. (1990) (176)
- Effects of Growth Hormone Administration on Inflammatory and Other Cardiovascular Risk Markers in Men with Growth Hormone Deficiency (2000) (174)
- Relationships between serum adipokines, insulin levels, and bone density in girls with anorexia nervosa. (2007) (173)
- Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. (2003) (172)
- Diagnostic errors after inferior petrosal sinus sampling. (2004) (170)
- Effects of prolactin and estrogen deficiency in amenorrheic bone loss. (1988) (168)
- Growth hormone (GH) replacement therapy in adult-onset gh deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial. (2004) (168)
- Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysis. (2001) (164)
- Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1-34): a randomized controlled trial. (1998) (163)
- Comparison of DXA and CT in the Assessment of Body Composition in Premenopausal Women With Obesity and Anorexia Nervosa (2010) (163)
- Body fat distribution measured with CT: correlations in healthy subjects, patients with anorexia nervosa, and patients with Cushing syndrome. (1989) (161)
- Decreased leptin levels in normal weight women with hypothalamic amenorrhea: the effects of body composition and nutritional intake. (1998) (159)
- Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy. (2000) (158)
- Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men. (2000) (157)
- FGF21 and the late adaptive response to starvation in humans. (2015) (156)
- Increased expression of angiogenic genes in the brains of mouse meg3-null embryos. (2010) (156)
- Clinical review 117: Hormonal determinants and disorders of peak bone mass in children. (2000) (155)
- Weight gain and restoration of menses as predictors of bone mineral density change in adolescent girls with anorexia nervosa-1. (2008) (154)
- Hormone production in clinically nonfunctioning pituitary adenomas. (1987) (152)
- Loss of expression of GADD45 gamma, a growth inhibitory gene, in human pituitary adenomas: implications for tumorigenesis. (2002) (152)
- Pulsatile secretion of thyrotropin in man. (1986) (150)
- Glycoprotein hormone genes are expressed in clinically nonfunctioning pituitary adenomas. (1987) (147)
- Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids, and insulin resistance in overweight girls. (2008) (146)
- The retinoblastoma gene in human pituitary tumors. (1993) (142)
- Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism. (2004) (140)
- Bone Metabolism in Adolescent Athletes With Amenorrhea, Athletes With Eumenorrhea, and Control Subjects (2008) (138)
- Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. (1993) (138)
- Hormonal and body composition predictors of soluble leptin receptor, leptin, and free leptin index in adolescent girls with anorexia nervosa and controls and relation to insulin sensitivity. (2004) (138)
- Primary medical therapy of micro- and macroprolactinomas in men. (2000) (137)
- Fracture risk and areal bone mineral density in adolescent females with anorexia nervosa. (2014) (137)
- Activation of paternally expressed genes and perinatal death caused by deletion of the Gtl2 gene (2010) (136)
- Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea. (1992) (136)
- Effects of Testosterone and Progressive Resistance Training in Eugonadal Men with AIDS Wasting (2000) (136)
- Hypercortisolemia is associated with severity of bone loss and depression in hypothalamic amenorrhea and anorexia nervosa. (2009) (134)
- Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial. (2000) (132)
- Nutrient intake in community-dwelling adolescent girls with anorexia nervosa and in healthy adolescents. (2006) (132)
- Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use. (2000) (131)
- Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. (1987) (130)
- Food motivation circuitry hypoactivation related to hedonic and nonhedonic aspects of hunger and satiety in women with active anorexia nervosa and weight-restored women with anorexia nervosa. (2012) (129)
- Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study. (2011) (125)
- Long-term mortality after transsphenoidal surgery for Cushing disease. (1999) (125)
- Ghrelin and bone metabolism in adolescent girls with anorexia nervosa and healthy adolescents. (2005) (124)
- Diagnosis and management of hormone-secreting pituitary adenomas. (1991) (124)
- Delayed remission after transsphenoidal surgery in patients with Cushing's disease. (2010) (122)
- Effects of exercise training and metformin on body composition and cardiovascular indices in HIV-infected patients (2004) (122)
- Anorexia nervosa and osteoporosis (2007) (121)
- Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomas. (2008) (121)
- Androgen deficiency in women with hypopituitarism. (2001) (119)
- Secretory dynamics of ghrelin in adolescent girls with anorexia nervosa and healthy adolescents. (2005) (118)
- Endocrine abnormalities in anorexia nervosa (2008) (116)
- Long-Term Mortality after Transsphenoidal Surgery for Cushing Disease (1999) (114)
- ras mutations in human prolactinomas and pituitary carcinomas. (1994) (114)
- Effects of rhIGF-I administration on bone turnover during short-term fasting. (1995) (113)
- Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents (2003) (112)
- Androgens in women with anorexia nervosa and normal-weight women with hypothalamic amenorrhea. (2007) (112)
- Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant. (2002) (112)
- Leptin levels are associated with decreased depressive symptoms in women across the weight spectrum, independent of body fat (2012) (111)
- Growth hormone and ghrelin responses to an oral glucose load in adolescent girls with anorexia nervosa and controls. (2004) (111)
- Hormone predictors of abnormal bone microarchitecture in women with anorexia nervosa. (2010) (111)
- Clinical Review#: Potential cardiac valve effects of dopamine agonists in hyperprolactinemia. (2010) (110)
- Oxytocin secretion is associated with severity of disordered eating psychopathology and insular cortex hypoactivation in anorexia nervosa. (2012) (110)
- Preservation of neuroendocrine control of reproductive function despite severe undernutrition. (2004) (110)
- Clinical review 45: Clinically nonfunctioning pituitary adenomas. (1993) (110)
- Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency. (2000) (109)
- Anorexia nervosa and bone. (2013) (109)
- Changing patterns in diagnosis and therapy of acromegaly over two decades. (2008) (108)
- Decreased nocturnal oxytocin levels in anorexia nervosa are associated with low bone mineral density and fat mass. (2011) (108)
- Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial. (2000) (107)
- Regional cerebral brain metabolism correlates of neuroticism and extraversion (2006) (105)
- Changes in regional fat redistribution and the effects of estrogen during spontaneous weight gain in women with anorexia nervosa. (2001) (103)
- Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa. (2008) (102)
- Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas. (2008) (102)
- Decreased bone formation and increased mineral dissolution during acute fasting in young women. (1995) (101)
- Determinants of GH resistance in malnutrition. (2014) (100)
- Adolescent girls with anorexia nervosa have impaired cortical and trabecular microarchitecture and lower estimated bone strength at the distal radius. (2013) (100)
- Assessment of growth hormone (GH) secretion in men with adult-onset GH deficiency compared with that in normal men--a clinical research center study. (1996) (100)
- Marrow fat and preadipocyte factor‐1 levels decrease with recovery in women with anorexia nervosa (2012) (99)
- Cortical microstructure and estimated bone strength in young amenorrheic athletes, eumenorrheic athletes and non-athletes. (2012) (99)
- Young women with cold-activated brown adipose tissue have higher bone mineral density and lower Pref-1 than women without brown adipose tissue: a study in women with anorexia nervosa, women recovered from anorexia nervosa, and normal-weight women. (2012) (99)
- Effects of risedronate on bone density in anorexia nervosa. (2004) (98)
- Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome. (2001) (98)
- Reproductive function during fasting in men. (1981) (98)
- Serum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly. (1995) (97)
- Amenorrheic Bone Loss (1999) (96)
- Bone metabolism in adolescent boys with anorexia nervosa. (2008) (95)
- Somatostatin receptor-specific analogs: effects on cell proliferation and growth hormone secretion in human somatotroph tumors. (2001) (94)
- Using quantitative CT to assess adipose distribution in adult men with acquired hypogonadism. (1998) (93)
- Hypothalmic Amenorrhea in Runners of Normal Body Composition (1980) (93)
- Teriparatide increases bone formation and bone mineral density in adult women with anorexia nervosa. (2014) (93)
- Current management practices for acromegaly: an international survey (2011) (93)
- Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing's disease. (1992) (93)
- Serum osteoprotegerin in adolescent girls with anorexia nervosa. (2003) (92)
- Inflammatory cardiovascular risk markers in women with hypopituitarism. (2001) (92)
- Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder (2002) (91)
- Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas. (1998) (91)
- Optimizing control of acromegaly: integrating a growth hormone receptor antagonist into the treatment algorithm. (2003) (91)
- Marrow fat composition in anorexia nervosa. (2014) (90)
- Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma (2014) (90)
- Effects of recombinant human growth hormone in anorexia nervosa: a randomized, placebo-controlled study. (2010) (89)
- Stress response circuitry hypoactivation related to hormonal dysfunction in women with major depression. (2011) (88)
- Role of Cortisol in Menstrual Recovery in Adolescent Girls with Anorexia Nervosa (2006) (87)
- Distal radius in adolescent girls with anorexia nervosa: trabecular structure analysis with high-resolution flat-panel volume CT. (2008) (87)
- Effects of fasting and glucose infusion on basal and overnight leptin concentrations in normal-weight women. (1997) (86)
- Preadipocyte factor-1 is associated with marrow adiposity and bone mineral density in women with anorexia nervosa. (2010) (86)
- Pure alpha-secreting pituitary adenomas. (1981) (86)
- Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk. (2005) (85)
- Nonsecreting pituitary tumors. (1987) (85)
- Hypogonadism in patients with acromegaly: data from the multi‐centre acromegaly registry pilot study (2001) (85)
- Age and bone mass in premenopausal women (1989) (85)
- Silencing of the imprinted DLK1-MEG3 locus in human clinically nonfunctioning pituitary adenomas. (2011) (85)
- Effects of rhIGF-1 administration on surrogate markers of bone turnover in adolescents with anorexia nervosa. (2009) (84)
- Testosterone administration in women with anorexia nervosa. (2005) (84)
- Peptide YY in adolescent athletes with amenorrhea, eumenorrheic athletes and non-athletic controls. (2009) (83)
- Osteopenia in Women With Hypothalamic Amenorrhea: A Prospective Study (1991) (83)
- Lymphocytic adenohypophysitis of pregnancy with complete recovery. (1987) (81)
- Effects of testosterone and exercise on muscle leanness in eugonadal men with AIDS wasting. (2001) (81)
- Effects of recombinant human growth hormone therapy in adults with Prader–Willi syndrome: a meta‐analysis (2012) (81)
- HPA-axis hormone modulation of stress response circuitry activity in women with remitted major depression (2013) (81)
- Sex differences in episodic memory in early midlife: impact of reproductive aging (2017) (77)
- DOPAMINERGIC MODULATION OF TSH AND ITS SUBUNITS: IN VIVO AND IN VITRO STUDIES (1983) (77)
- Prolactin pulsatile characteristics in postmenopausal women. (1998) (76)
- Bone health in anorexia nervosa (2011) (75)
- Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled study. (2008) (75)
- Fibroblast growth factor-21 may mediate growth hormone resistance in anorexia nervosa. (2010) (75)
- Regional body composition in adolescents with anorexia nervosa and changes with weight recovery. (2003) (73)
- The Neuroendocrine Basis of Anorexia Nervosa and Its Impact on Bone Metabolism (2011) (71)
- Age and bone mass in premenopausal women. (1990) (71)
- Clinical review 117: Hormonal determinants and disorders of peak bone mass in children (2000) (70)
- Appetite-regulating hormones cortisol and peptide YY are associated with disordered eating psychopathology, independent of body mass index. (2011) (70)
- Effects of recombinant human growth hormone therapy on bone mineral density in adults with growth hormone deficiency: a meta-analysis. (2014) (70)
- Differential effects of metformin and exercise on muscle adiposity and metabolic indices in human immunodeficiency virus-infected patients. (2004) (67)
- Proton stereotactic radiosurgery in management of persistent acromegaly. (2007) (66)
- Acylated ghrelin and leptin in adolescent athletes with amenorrhea, eumenorrheic athletes and controls: a cross‐sectional study (2008) (66)
- Clinical features of nonpituitary sellar lesions in a large surgical series (2010) (66)
- Prevalence of alpha-subunit hypersecretion in patients with pituitary tumors: clinically nonfunctioning and somatotroph adenomas. (1990) (65)
- Tumor-specific expression and alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-beta receptors in human pituitary adenomas. (1996) (65)
- Clinically silent hypersecretion of growth hormone in patients with pituitary tumors. (1987) (64)
- Neuroendocrine consequences of anorexia nervosa in adolescents. (2010) (64)
- Cortisol Measures Across the Weight Spectrum. (2015) (63)
- The circulating metabolome of human starvation. (2018) (62)
- Quantitative assessment of cross-sectional muscle area, functional status, and muscle strength in men with the acquired immunodeficiency syndrome wasting syndrome. (1999) (62)
- Chronic somatostatin analog administration in patients with alpha-subunit-secreting pituitary tumors. (1992) (62)
- Prognostic indicators of changes in bone density measures in adolescent girls with anorexia nervosa-II. (2008) (61)
- Luteinizing hormone-secreting pituitary tumor: biosynthetic characterization and clinical studies. (1987) (61)
- Growth hormone deficiency is associated with decreased quality of life in patients with prior acromegaly. (2009) (60)
- Tumor suppression by MEG3 lncRNA in a human pituitary tumor derived cell line (2015) (59)
- Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: a randomized controlled trial. (2001) (59)
- Determinants of increased energy expenditure in HIV-infected women. (1998) (59)
- Impact of Sex and Menopausal Status on Episodic Memory Circuitry in Early Midlife (2016) (58)
- Treatment of prolactin-secreting pituitary macroadenomas with the long-acting non-ergot dopamine agonist CV 205-502. (1990) (58)
- Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy. (1984) (58)
- 17β-Estradiol Differentially Regulates Stress Circuitry Activity in Healthy and Depressed Women (2015) (57)
- Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors. (1989) (56)
- Cyclic AMP stimulates MEG3 gene expression in cells through a cAMP-response element (CRE) in the MEG3 proximal promoter region. (2006) (55)
- Testosterone administration attenuates regional brain hypometabolism in women with anorexia nervosa (2004) (55)
- Eating disorders. (2019) (54)
- Tumor-specific expression of alternatively spliced estrogen receptor messenger ribonucleic acid variants in human pituitary adenomas. (1997) (54)
- Reorganization of Functional Networks in Verbal Working Memory Circuitry in Early Midlife: The Impact of Sex and Menopausal Status (2016) (53)
- Mechanisms and treatment options for bone loss in anorexia nervosa. (1997) (53)
- Concomitant medication use can confound interpretation of the combined dexamethasone-corticotropin releasing hormone test in Cushing's syndrome. (2009) (53)
- Glycoprotein hormone alpha-subunit production in somatotroph adenomas with and without Gs alpha mutations. (1992) (52)
- Hormonal determinants of regional body composition in adolescent girls with anorexia nervosa and controls. (2005) (52)
- Hormonal responses to short term fasting in postmenopausal women. (1985) (52)
- Effects of estrogen and recombinant human insulin-like growth factor-I on ghrelin secretion in severe undernutrition. (2004) (51)
- Imbalanced follicle-stimulating hormone beta-subunit hormone biosynthesis in human pituitary adenomas. (1992) (51)
- Accuracy of Late-Night Salivary Cortisol in Evaluating Postoperative Remission and Recurrence in Cushing's Disease. (2015) (50)
- Increased hypothalamic-pituitary-adrenal drive is associated with decreased appetite and hypoactivation of food-motivation neurocircuitry in anorexia nervosa. (2013) (50)
- Parathyroid Hormone for the Prevention of Bone Loss Induced by Estrogen Deficiency (1995) (50)
- Oestrogen replacement improves bone mineral density in oligo-amenorrhoeic athletes: a randomised clinical trial (2018) (50)
- Androgen deficiency: association with increased anxiety and depression symptom severity in anorexia nervosa. (2007) (50)
- Activin effects on neoplastic proliferation of human pituitary tumors. (2000) (50)
- Sustained anabolic effects of long-term androgen administration in men with AIDS wasting. (1999) (50)
- Postprandial oxytocin secretion is associated with severity of anxiety and depressive symptoms in anorexia nervosa. (2013) (50)
- A human pituitary tumor-derived folliculostellate cell line. (2000) (49)
- Adipokines and Cardiovascular Risk in Cushing’s Syndrome (2011) (49)
- Effects of Growth Hormone on Bone. (2016) (49)
- Endocrinology of anorexia nervosa in young people: recent insights (2014) (48)
- Nocturnal oxytocin secretion is lower in amenorrheic athletes than nonathletes and associated with bone microarchitecture and finite element analysis parameters. (2013) (47)
- Pure alpha subunit-secreting pituitary tumors. (1983) (47)
- Bone metabolism in adolescents with anorexia nervosa (2011) (46)
- Age alters pulsatile prolactin release: influence of dopaminergic inhibition. (1990) (46)
- Anorexia Nervosa and Its Associated Endocrinopathy in Young People (2016) (46)
- Impaired bone strength estimates at the distal tibia and its determinants in adolescents with anorexia nervosa. (2018) (45)
- Brain hypoactivation, autonomic nervous system dysregulation, and gonadal hormones in depression: A preliminary study (2012) (45)
- Investigation of impulsivity in patients on dopamine agonist therapy for hyperprolactinemia: a pilot study (2014) (45)
- Truncated activin type I receptor Alk4 isoforms are dominant negative receptors inhibiting activin signaling. (2000) (45)
- Elevated serum lipids in hypogonadal men with and without hyperprolactinemia. (1989) (45)
- Serum prolactin levels among outpatients with major depressive disorder during the acute phase of treatment with fluoxetine. (2006) (44)
- Comparison of hip geometry, strength, and estimated fracture risk in women with anorexia nervosa and overweight/obese women. (2014) (44)
- Predictors of Hypopituitarism in Patients with Traumatic Brain Injury. (2015) (44)
- Abnormal relationships between the neural response to high- and low-calorie foods and endogenous acylated ghrelin in women with active and weight-recovered anorexia nervosa (2014) (44)
- Corrigendum: Region-specific variation in the properties of skeletal adipocytes reveals regulated and constitutive marrow adipose tissues (2016) (43)
- Determinants of IGF1 and GH across the weight spectrum: from anorexia nervosa to obesity. (2010) (43)
- Anorexia nervosa and bone metabolism. (2014) (43)
- Comparison of pegvisomant and long-acting octreotide in patients with acromegaly naïve to radiation and medical therapy. (2009) (42)
- Positive effects of brown adipose tissue on femoral bone structure. (2014) (42)
- Women with anorexia nervosa: finite element and trabecular structure analysis by using flat-panel volume CT. (2010) (42)
- Oxytocin and Its Relationship to Body Composition, Bone Mineral Density, and Hip Geometry Across the Weight Spectrum (2017) (42)
- Serum FGF-21 levels are associated with worsened radial trabecular bone microarchitecture and decreased radial bone strength in women with anorexia nervosa. (2015) (42)
- Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting. (1998) (42)
- Simultaneous initiation (coinitiation) of pharmacotherapy with triiodothyronine and a selective serotonin reuptake inhibitor for major depressive disorder: a quantitative synthesis of double-blind studies (2009) (41)
- Hip structural analysis in adolescent boys with anorexia nervosa and controls. (2013) (41)
- Appetite regulatory hormones in women with anorexia nervosa: binge-eating/purging versus restricting type. (2015) (41)
- Current Status and Future Opportunities for Controlling Acromegaly (2004) (41)
- Somatostatin regulation of glycoprotein hormone and free subunit secretion in clinically nonfunctioning and somatotroph adenomas in vitro. (1991) (41)
- Impact of physiologic estrogen replacement on anxiety symptoms, body shape perception, and eating attitudes in adolescent girls with anorexia nervosa: data from a randomized controlled trial. (2013) (40)
- Uncoupling of cardiovascular risk markers in adolescent girls with anorexia nervosa. (2006) (39)
- Age-related alterations in pulsatile secretion of TSH: role of dopaminergic regulation. (1991) (39)
- Erratum: Safety and efficacy of long term octreotide therapy of acromegaly: Results of a multicenter trial in 103 patients - A clinical research center study (Journal of Clinical Endocrinoloy and Metabolism (1995) 80 (2768-2775)) (1995) (39)
- Human pituitary adenomas express endogenous inhibin subunit and follistatin messenger ribonucleic acids. (1995) (39)
- Effects of Anorexia Nervosa on Bone Metabolism (2018) (39)
- Gonadotropin-releasing hormone messenger RNA expression in gonadotroph tumors and normal human pituitary. (1996) (39)
- Sclerostin levels and bone turnover markers in adolescents with anorexia nervosa and healthy adolescent girls. (2012) (39)
- Adrenal glucocorticoid and androgen precursor dissociation in anorexia nervosa. (2009) (39)
- Reduced amylin levels are associated with low bone mineral density in women with anorexia nervosa. (2010) (38)
- Mutational analysis of activin/transforming growth factor-beta type I and type II receptor kinases in human pituitary tumors. (1999) (38)
- Psychotropic medication use in anorexia nervosa between 1997 and 2009. (2012) (37)
- Intravertebral fat measurement with quantitative CT in patients with Cushing disease and anorexia nervosa. (1989) (37)
- Gender effects on cardiac valvular function in hyperprolactinaemic patients receiving cabergoline: a retrospective study (2010) (37)
- Dopamine Agonists Can Reduce Cystic Prolactinomas. (2016) (37)
- Treatment With a Ghrelin Agonist in Outpatient Women With Anorexia Nervosa: A Randomized Clinical Trial. (2018) (37)
- Effects of growth hormone deficiency on body composition and biomarkers of cardiovascular risk after definitive therapy for acromegaly (2012) (37)
- Dopaminergic Regulation of a-Subunit Secretion and Messenger Ribonucleic Acid Levels in a-Secreting Pituitary Tumors* (1988) (36)
- Effects of recombinant human insulin-like growth factor (IGF)-I and estrogen administration on IGF-I, IGF binding protein (IGFBP)-2, and IGFBP-3 in anorexia nervosa: a randomized-controlled study. (2003) (36)
- Endocrine function following high dose proton therapy for tumors of the upper clivus. (1988) (36)
- Bone density, body composition, and psychopathology of anorexia nervosa spectrum disorders in DSM‐IV vs DSM‐5 (2017) (36)
- Clinical review 106: Amenorrheic bone loss. (1999) (35)
- Increased Carbohydrate Induced Ghrelin Secretion in Obese vs. Normal‐weight Adolescent Girls (2009) (35)
- Growth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement. (2010) (34)
- Determinants of Height in Adolescent Girls With Anorexia Nervosa (2008) (34)
- Body Composition and Skeletal Health: Too Heavy? Too Thin? (2012) (34)
- Regulation of growth hormone expression by Delta-like protein 1 (Dlk1) (2007) (34)
- Effects of a growth hormone receptor antagonist on bone markers in acromegaly (2002) (34)
- Waist to hip ratio and trunk to extremity fat (DXA) are better surrogates for IMCL and for visceral fat respectively than for subcutaneous fat in adolescent girls (2010) (34)
- Eating disorders [5] (1999) (32)
- Effects of growth hormone secretion on body composition in patients with Crohn's disease. (2003) (32)
- Reciprocal changes in endogenous ghrelin and growth hormone during fasting in healthy women. (2005) (30)
- Receptor internalization-independent activation of Smad2 in activin signaling. (2004) (30)
- Neuroactive Steroids and Affective Symptoms in Women Across the Weight Spectrum (2017) (30)
- Effects of testosterone therapy on cardiovascular risk markers in androgen-deficient women with hypopituitarism. (2007) (30)
- Ricin and lentil lectin-affinity chromatography reveals oligosaccharide heterogeneity of thyrotropin secreted by 12 human pituitary tumors. (1992) (30)
- Comparison of pegvisomant and long-acting octreotide in patients with acromegaly naïve to radiation and medical therapy (2009) (29)
- Bone microarchitecture and estimated bone strength in men with active acromegaly. (2017) (29)
- Relative growth hormone deficiency and cortisol excess are associated with increased cardiovascular risk markers in obese adolescent girls. (2009) (29)
- Bone Metabolism in Anorexia Nervosa (2014) (29)
- Gonadotropin-releasing hormone receptor mRNA expression by human pituitary tumors in vitro. (1994) (29)
- Accuracy of laboratory tests for the diagnosis of Cushing's syndrome. (2020) (28)
- Inhibition of Pref‐1 (preadipocyte factor 1) by oestradiol in adolescent girls with anorexia nervosa is associated with improvement in lumbar bone mineral density (2013) (28)
- Androgens and bone density in women with hypopituitarism. (2002) (28)
- Direct adrenergic stimulation of the release of thyrotropin and its subunits from the thyrotrope in vitro. (1983) (28)
- Management of recurrent and refractory Cushing's disease with reoperation and/or proton beam radiosurgery. (2007) (27)
- Dopamine agonist therapy in prolactinomas: when can treatment be discontinued? (2009) (27)
- Sex differences, hormones, and fMRI stress response circuitry deficits in psychoses (2015) (27)
- Expression of prolactin-releasing peptide and its receptor messenger ribonucleic acid in normal human pituitary and pituitary adenomas. (1999) (27)
- IGFBP-2 is a negative predictor of cold-induced brown fat and bone mineral density in young non-obese women. (2013) (26)
- Use of SSRIs May Impact Bone Density in Adolescent and Young Women With Anorexia Nervosa (2010) (26)
- Vertebral Strength and Estimated Fracture Risk Across the BMI Spectrum in Women (2016) (26)
- Central diabetes insipidus: a previously unreported side effect of temozolomide. (2013) (26)
- Overexpression of wild-type activin receptor alk4-1 restores activin antiproliferative effects in human pituitary tumor cells. (2002) (25)
- Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysis. (2014) (25)
- Isolation and characterization of novel pituitary tumor related genes: A cDNA representational difference approach (2010) (25)
- Transsphenoidal surgery for cushing disease after nondiagnostic inferior petrosal sinus sampling. (2012) (25)
- MRI texture analysis as a predictor of tumor recurrence or progression in patients with clinically non-functioning pituitary adenomas. (2018) (25)
- Suboptimal bone microarchitecure in adolescent girls with obesity compared to normal-weight controls and girls with anorexia nervosa. (2019) (25)
- Bone mineral density and estimated hip strength in men with anorexia nervosa, atypical anorexia nervosa and avoidant/restrictive food intake disorder (2019) (24)
- Editorial Response: What Price Progress? Pseudo-Cushing's Syndrome Associated with Antiretroviral Therapy in Patients with Human Immunodeficiency Virus Infection (1998) (23)
- Treatment of ACTH-dependent Cushing ’ s syndrome : a consensus statement (2008) (23)
- The effects of activin on follicle-stimulating hormone secretion and biosynthesis in human glycoprotein hormone-producing pituitary adenomas. (1991) (23)
- Impact of low‐weight severity and menstrual status on bone in adolescent girls with anorexia nervosa (2017) (23)
- Anorexia nervosa, obesity and bone metabolism. (2013) (23)
- Case records of the Massachusetts General Hospital. Case 36-2006. A 35-year-old pregnant woman with new hypertension. (2006) (23)
- The effect of somatostatin on the release of thyrotropin and its subunits from bovine anterior pituitary cells in vitro. (1983) (23)
- Effects of Anorexia Nervosa on the Endocrine System. (2017) (23)
- Hypothalamic amenorrhea in runners of normal body composition. (1981) (23)
- Hormonal and nutritional effects on cardiovascular risk markers in young women. (2007) (23)
- Percentage extremity fat, but not percentage trunk fat, is lower in adolescent boys with anorexia nervosa than in healthy adolescents. (2008) (23)
- Peptide YY levels across pubertal stages and associations with growth hormone. (2010) (22)
- Comment on Normal Volumetric Bone Mineral Density and Bone Turnover in Young Men with Histories of Constitutional Delay of Puberty (1999) (22)
- Hypoglycemia from IGF2 overexpression associated with activation of fetal promoters and loss of imprinting in a metastatic hemangiopericytoma. (2009) (22)
- Vertebral Volumetric Bone Density and Strength Are Impaired in Women With Low-Weight and Atypical Anorexia Nervosa (2016) (22)
- Cardiovascular risk in patients with growth hormone deficiency: effects of growth hormone substitution. (2006) (22)
- Effectiveness of first-line pegvisomant monotherapy in acromegaly: an ACROSTUDY analysis. (2017) (21)
- Testosterone Administration in Women With Anorexia Nervosa (2005) (21)
- Bone Parameters in Anorexia Nervosa and Athletic Amenorrhea: Comparison of Two Hypothalamic Amenorrhea States (2018) (21)
- Symptomatic salivary-rest cyst of the sella turcica (2005) (20)
- Effect of carbohydrate supplementation on reproductive hormones during fasting in men. (1985) (20)
- Anorexia Nervosa and Bone. (2018) (20)
- Evaluation and treatment of low bone density in anorexia nervosa. (2002) (20)
- Effects of growth hormone therapy on bone density and fracture risk in age-related osteoporosis in the absence of growth hormone deficiency: a systematic review and meta-analysis (2017) (20)
- Evaluation of lumber spine bone mineral density (BMD) using dual energy x-ray absorptiometry (DXA) in 21 young men with histories of constitutionally-delayed puberty. (1999) (19)
- Pulsatile gonadotropin secretion after discontinuation of long term gonadotropin-releasing hormone (GnRH) administration in a subset of GnRH-deficient men. (1989) (19)
- Growth hormone should be used only for approved indications. (2014) (19)
- Growth hormone is positively associated with surrogate markers of bone turnover during puberty (2011) (19)
- Prevalance of α-Subunit Hypersecretion in Patients with Pituitary Tumors: Clinically Nonfunctioning and Somatotroph Adenomas (1990) (19)
- MANAGEMENT OF ENDOCRINE DISEASE: Impulse control disorders in patients with hyperpolactinemia treated with dopamine agonists: how much should we worry? (2018) (19)
- Health Care Infrastructure for Financially Sustainable Clinical Genomics. (2016) (19)
- The effect of somatostatin analogs on vitamin D and calcium concentrations in patients with acromegaly (2014) (19)
- Growth hormone suppression after an oral glucose load in children. (2007) (19)
- The paradox of marrow adipose tissue in anorexia nervosa. (2018) (19)
- The treatment of hyperprolactinemia in postmenopausal women with prolactin-secreting microadenomas: Cons (2015) (19)
- Bone Density Characteristics and Major Depressive Disorder in Adolescents (2013) (18)
- Neural - hormonal responses to negative affective stimuli: Impact of dysphoric mood and sex. (2017) (18)
- Surgical debulking of pituitary adenomas improves responsiveness to octreotide lar in the treatment of acromegaly (2017) (18)
- Changes in marrow adipose tissue with short-term changes in weight in premenopausal women with anorexia nervosa. (2019) (18)
- Growth hormone and cardiovascular risk markers. (2003) (17)
- Further evidence for a somatic mutation theory in the pathogenesis of human pituitary tumors. (1990) (17)
- The Effects of Anorexia Nervosa on Bone Metabolism in Female Adolescents (2000) (17)
- Endogenous Oxytocin Levels in Relation to Food Intake, Menstrual Phase, and Age in Females (2018) (16)
- Anorexia Nervosa: Analysis of Trabecular Texture with CT. (2017) (16)
- The allopregnanolone to progesterone ratio across the menstrual cycle and in menopause (2019) (15)
- Serum prolactin concentrations in patients with the acquired immunodeficiency syndrome (1990) (15)
- Acylated Ghrelin and Leptin in Adolescent Athletes With Amenorrhea, Eumenorrheic Athletes and Controls : A Cross-Sectional Study (2009) (15)
- Effects of Estrogen Replacement on Bone Geometry and Microarchitecture in Adolescent and Young Adult Oligoamenorrheic Athletes: A Randomized Trial (2019) (15)
- Effect of growth hormone replacement therapy on the quality of life in women with growth hormone deficiency who have a history of acromegaly versus other disorders. (2012) (15)
- Plasma sodium level is associated with bone loss severity in women with anorexia nervosa: a cross-sectional study. (2012) (15)
- A randomized placebo-controlled trial of low-dose testosterone therapy in women with anorexia nervosa. (2019) (14)
- Trabecular structure analysis of the distal radius in adolescent patients with anorexia nervosa using ultra high resolution flat panel based volume CT. (2008) (14)
- Growth hormone status predicts left ventricular mass in patients after cure of acromegaly. (2010) (14)
- A decade of the Massachusetts General Hospital Neuroendocrine Clinical Center. (1997) (14)
- Red and White Blood Cell Counts Are Associated With Bone Marrow Adipose Tissue, Bone Mineral Density, and Bone Microarchitecture in Premenopausal Women (2020) (14)
- Prolactin response to thyrotropin-releasing hormone (TRH) in patients with hypothalamic-pituitary disease. (1985) (13)
- A patient with diabetes insipidus, anterior hypopituitarism and pituitary stalk thickening (2011) (13)
- The dynamics of human bone marrow adipose tissue in response to feeding and fasting (2021) (13)
- Pathologic and clinical features of pituitary adenomas showing TSH immunoreactivity (2013) (13)
- Effects of Risedronate and Low-Dose Transdermal Testosterone on Bone Mineral Density in Women With Anorexia Nervosa: A Randomized, Placebo-Controlled Study (2011) (13)
- Macronutrient intake associated with weight gain in adolescent girls with anorexia nervosa (2017) (12)
- The long non-coding RNA Meg3 is dispensable for hematopoietic stem cells (2019) (12)
- The importance of dopamine in the pathogenesis of experimental prolactinomas. (1990) (12)
- Divergent associations between ghrelin and neural responsivity to palatable food in hyperphagic and hypophagic depression. (2019) (12)
- Medical therapy of glycoprotein hormone-secreting pituitary tumors. (1989) (12)
- alpha-Subunit and gonadotropin responses to luteinizing hormone-releasing hormone in hyperprolactinemic women before and after bromocriptine. (1983) (11)
- Differences in trabecular plate and rod structure in premenopausal women across the weight spectrum. (2019) (10)
- Dopaminergic regulation of alpha-subunit secretion and messenger ribonucleic acid levels in alpha-secreting pituitary tumors. (1988) (10)
- Impact of BDNF and sex on maintaining intact memory function in early midlife (2019) (10)
- Prolactin and Its Role in Human Reproduction (2019) (10)
- Neuroendocrine disorders: pituitary imaging. (2016) (10)
- Disrupted oxytocin-appetite signaling in females with anorexia nervosa. (2019) (9)
- Fat Attenuation at CT in Anorexia Nervosa. (2016) (9)
- The endocrine tumor summit 2008: appraising therapeutic approaches for acromegaly and carcinoid syndrome (2009) (9)
- SEVERITY OF OSTEOPENIA IN ESTROGEN-DEFICIENT WOMEN WITH ANOREXIA NERVOSA AND HYPOTHALAMIC AMENORRHEA (1999) (9)
- Prolactin Secreting Pituitary Tumors in Men (2001) (9)
- Effects of androgens on bone metabolism (1990) (8)
- Modulation of neural fMRI responses to visual food cues by overeating and fasting interventions: A preliminary study (2020) (8)
- MRI texture analysis in acromegaly and its role in predicting response to somatostatin receptor ligands (2020) (8)
- Characterization of cyclic Cushing's disease using late night salivary cortisol testing (2018) (8)
- Bone marrow adipose tissue composition following high-caloric feeding and fasting. (2021) (8)
- Monotherapy with lanreotide depot for acromegaly: long-term clinical experience in a pituitary center (2016) (7)
- CLINICAL OUTCOMES AND SELF-REPORTED SYMPTOMS IN PATIENTS WITH ACROMEGALY: AN 8-YEAR FOLLOW-UP OF A LANREOTIDE STUDY. (2017) (7)
- What price progress? Pseudo-Cushing's syndrome associated with antiretroviral therapy in patients with human immunodeficiency virus infection. (1998) (7)
- Effect of Transdermal Estradiol and Insulin-Like Growth Factor-1 on Bone Endpoints of Young Women with Anorexia Nervosa. (2021) (7)
- The role of the clinical laboratory in the diagnosis of Cushing syndrome. (2003) (7)
- Catecholestrogen regulation of prolactin synthesis in pituitary cell culture. (1985) (6)
- Traumatic brain injury: effects on the endocrine system. (2013) (5)
- Acromegalic Heart Disease (1998) (5)
- ALL-CAUSE MORTALITY IN PATIENTS WITH ACROMEGALY TREATED WITH PEGVISOMANT AN ACROSTUDY ANALYSIS. (2020) (5)
- Diagnostic Dilemmas in the Management of Hypothalamic‐Pituitary‐Adrenal Disorders (1987) (5)
- Meg3-DMR, not the Meg3 gene, regulates imprinting of the Dlk1-Dio3 locus. (2019) (4)
- Osteoporosis and Hyperprolactinemia (1984) (4)
- Erratum: Hypogonadism in patients with acromegaly: Data from the multicentre acromegaly registry pilot study (Clinical Endocrinology 54 (183-188)) (2001) (4)
- Sequential Therapy With Recombinant Human IGF‐1 Followed by Risedronate Increases Spine Bone Mineral Density in Women With Anorexia Nervosa: A Randomized, Placebo‐Controlled Trial (2021) (4)
- IGF-1 is associated with estimated bone strength in anorexia nervosa (2019) (4)
- State-of-the-art strategies for the diagnosis and management of acromegaly (2001) (4)
- Effect of growth hormone treatment on diastolic function in patients who have developed growth hormone deficiency after definitive treatment of acromegaly. (2016) (3)
- Erratum to: Impact of low-weight severity and menstrual status on bone in adolescent girls with anorexia nervosa. (2017) (3)
- Changes in Marrow Adipose Tissue in Relation to Changes in Bone Parameters Following Estradiol Replacement in Adolescent and Young Adult Females with Functional Hypothalamic Amenorrhea. (2021) (3)
- Correction to: Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement (2018) (3)
- Divergent dopaminergic regulation of TSH, free α-subunit, and TSH-β in pituitary cell culture (1986) (3)
- Growth Hormone Replacement Therapy in Adult Onset GH Deficiency : Effects on Body Composition in Men and Women in a Double-Blind , Randomized , Placebo-Controlled Trial (2005) (3)
- A cross-nearest neighbor/Monte Carlo algorithm for single-molecule localization microscopy defines interactions between p53, Mdm2, and MEG3 (2019) (3)
- Hypercalcemia and local production of parathyroid hormone-related protein by a perisellar rhabdomyosarcoma after remote pituitary irradiation. (2005) (3)
- Neuroendocrine dysregulation and the growth hormone–IGF-1 axis in anorexia nervosa (2012) (3)
- High Histone Deacetylase 2/3 Expression in Non-Functioning Pituitary Tumors (2022) (2)
- Amenorrhea and Osteoporosis (1991) (2)
- Eating Disorders: Evaluation and Management (2008) (2)
- Physiologic Transdermal Estradiol Replacement Mimics Effects of Endogenous Estrogen on Bone Outcomes in Hypoestrogenic Women with Anorexia Nervosa (2022) (2)
- Hyperprolactinemia. (2015) (2)
- A comparison between the efficacy and safety of pegvisomant to that of octreotide LAR in patients with acromegaly (2007) (2)
- Cardiovascular risk markers in hypothalamic amenorrhoea (2000) (2)
- Progressive Trabecular Osteopenia in Women With Hyperprolactinemic Amenorrhea (1993) (2)
- TWO SYNCHRONOUS PITUITARY ADENOMAS CAUSING CUSHING DISEASE AND ACROMEGALY. (2019) (2)
- Biochemical Assessment in Patients with Cushing’s Disease due to Corticotroph Macroadenomas—Authors’ Response (1999) (2)
- Visceral Fat Is a Negative Predictor of Bone Density Measures in Obese Adolescent Girls (2010) (2)
- SUN-350 Bone Marrow Adipose Tissue Is Associated with Fracture Prevalence in Anorexia Nervosa (2020) (1)
- Octreotide Treatment of Acromegaly (2020) (1)
- Pituitary function following high dose proton therapy for tumors of the upper clivus (1987) (1)
- SAT-441 Oxytocin Levels Are Associated with Psychopathology in Restricting but Not Binge-Purge Subtype of Anorexia Nervosa (2019) (1)
- Acknowledgement of reviewers 2011 (2012) (1)
- The Androgen Deficiency Syndrome in Women (2002) (1)
- in Clinically Nonfunctioning Pituitary Adenomas (1987) (1)
- The interaction between p53 and Mdm2 is independent of MEG3–p53 association (2019) (1)
- MON-335 Phenocopy of Multiple Endocrine Neoplasia Type 1 (MEN1) Due to a Germline Cell Division Cycle 73 (CDC73) Variant (2019) (1)
- Indications for Treatment of Hyperprolactinemia: An Overview (1997) (1)
- Regional Osteoporosis in Anorexia Nervosa (2001) (1)
- Hypoglycemia from IGF2 Overexpression Associated with Activation of Fetal Promoters and Loss of Imprinting in a Metastatic Hemangiopericytoma (2009) (1)
- 102 Hypothalamic-pituitary gland dysfunction following high dose conformal mixed proton/photon radiotherapy to the base of skull region: demonstration of a dose effect relationship using dose volume histogram analysis (1999) (1)
- C-arm CT for histomorphometric evaluation of lumbar spine trabecular microarchitecture: a study on anorexia nervosa patients. (2013) (1)
- Cardiovascular Risk in Women with Hypopituritarism (2002) (1)
- CHARACTERIZATION OF NON-FUNCTIONING PITUITARY ADENOMAS BY LIGHT AND ELECTRON MICROSCOPIC IMMUNOCYTOCHEMISTRY (1986) (0)
- Sprouting Angiogenesis in Human Pituitary Adenomas (2022) (0)
- Low oxytocin levels are broadly associated with more pronounced psychopathology in anorexia nervosa with primarily restricting but not binge/purge eating behavior (2023) (0)
- Measurement of Trabecular Bone Quality In Vivo using Decay due to Diffusion in the Internal Field ( DDIF ) MRI (2013) (0)
- Correction: Postprandial oxytocin secretion is associated with severity of anxiety and depressive symptoms in anorexia nervosa. (2015) (0)
- SAT-273 Suboptimal Bone Adaptation to Increasing Body Weight in Adolescents across the Nutritional Spectrum of Anorexia Nervosa, Normal Weight, and Obesity (2019) (0)
- Neuropsychiatric Disorders and the Skeleton (2018) (0)
- Sequential Therapy With Recombinant Human IGF-1 Followed by Risedronate Increases Spine Bone Mineral Density in Women With Anorexia Nervosa (2021) (0)
- MON-225 A Randomized Placebo-Controlled Trial of Low-Dose Testosterone Therapy in Women with Anorexia Nervosa (2019) (0)
- SAT-442 Endogenous Oxytocin Response to Food Intake in Anorexia Nervosa (2019) (0)
- Author response for "Red and white blood cell counts are associated with bone marrow adipose tissue, bone density and bone microarchitecture in premenopausal women" (2020) (0)
- Multiple endocrine neoplasia type 1 (MEN1) phenocopy due to a P.Leu380Phe cell division cycle 23 (CDC73) mutation (2017) (0)
- Impact of AN on Body Composition and Liver Function (2014) (0)
- Bone metabolism in adolescents with anorexia nervosa 324 (0)
- This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the author's clinical recommendations. Prolactinomas (2010) (0)
- MRI Texture Analysis as a Predictor of Tumor Recurrence or Progression in Patients with Clinically Non-Functioning Pituitary Adenomas (2018) (0)
- Divergent dopaminergic regulation of TSH, free alpha-subunit, and TSH-beta in pituitary cell culture. (1986) (0)
- Contributors (2019) (0)
- Bone marrow adipose tissue is associated with fracture history in anorexia nervosa (2022) (0)
- 14 – Secondary Amenorrhea (1999) (0)
- The long non-coding RNA Meg3 is dispensable for hematopoietic stem cells (2019) (0)
- Pituitary tumors: Back to basics (2003) (0)
- PITUITARY DISORDERS (2009) (0)
- Neuroendocrine regulation of bone mass - GH deficiency and resistance states (2003) (0)
- Medical Therapy of Prolactinomas in Men (2001) (0)
- PL11 Growth hormone: From starvation to obesity (2012) (0)
- Proton Stereotactic Radiotherapy for Treatment of Nelson's Syndrome. (2021) (0)
- Acknowledgement of reviewers 2013 (2014) (0)
- Plasma midkine concentrations in healthy children, children with increased and decreased adiposity, and children with short stature (2019) (0)
- The Effect of Short-Term High-Caloric Feeding and Fasting on Bone Microarchitecture. (2021) (0)
- OR03-6 Tibial and Radial Bone Structure as Assessed by HRpQCT May Explain Differences in Peripheral Skeletal Integrity and Fracture Risk Across the Weight Spectrum That Cannot Be Explained by Areal BMD Alone (2019) (0)
- E. Chester Ridgway, MD, MACP (1942-2014). (2014) (0)
- Tumorigenesis and Neoplastic Progression Silencing of the Imprinted DLK 1-MEG 3 Locus in Human Clinically Nonfunctioning Pituitary Adenomas (2011) (0)
- histomorphometri c evaluation of lumbar spine trabecular microarchitecture: a study on anorexia nervosa patients (2013) (0)
- Craniopharyngioma: Neuroendocrine Evaluation and Management (2015) (0)
- 2016 BIRCWH Presentation Abstracts O-1 : Promoting Tissue Integration via Release of IL-4 from the Surface of Polypropylene Mesh (2016) (0)
- Quality of Life in Patients Treated With Surgery Alone Versus Surgery and Radiation for Nonfunctioning Pituitary Adenomas (2014) (0)
- SUMMARY Endocrine abnormalities in anorexia nervosa (2008) (0)
- Eating Disorders and Their Effects on Bone Health (2015) (0)
- Author response for "Sequential therapy with recombinant human IGF ‐1 followed by risedronate increases spine bone mineral density in women with anorexia nervosa: A randomized, placebo‐controlled trial" (2021) (0)
- MGH New Faculty Orientation MGH New Faculty Orientation (2014) (0)
- SAT-167 Dehydroepiandrosterone Sulfate (DHEAS) Levels Predict Weight Gain in Women with Anorexia Nervosa (2020) (0)
- Prolactinomas and Hyperprolactinaemia (Including Macroprolactinaemia) (2021) (0)
- ODP053 Serum Free Cortisol and Free Cortisol-to-Cortisone Ratio Increase After 10 Days of Overfeeding and After 10 Days of Fasting (2022) (0)
- Long-Term Safety of Growth Hormone (GH) Replacement in Adults with GH Deficiency (GHD) Following Cure of Acromegaly - a Kims (Pfizer International Metabolic Database) Analysis (2014) (0)
- Bone marrow adipose tissue as a source of serum adiponectin: The (2013) (0)
- Placebo-Controlled Trial Effects on Body Composition in Men and Women in a Double-Blind, Randomized, Growth Hormone (GH) Replacement Therapy in Adult-Onset GH Deficiency: (2004) (0)
- Role of GnRH Receptors in the Pathogenesis of Pituitary Tumors1 (1996) (0)
- Pituitary Tumors: Future Perspectives (2000) (0)
- 14 Growth Hormone and Osteoporosis (0)
- Growth Hormone and Osteoporosis (2000) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Anne Klibanski?
Anne Klibanski is affiliated with the following schools:
